Index by author

November 1, 1999; Volume 40,Issue 11

  1. Abram, Ulrich

    1. Organometallic 99mTc-Aquaion Labels Peptide to an Unprecedented High Specific Activity
      André Egli, Roger Alberto, Lesley Tannahill, Roger Schibli, Ulrich Abram, Andreas Schaffland, Robert Waibel, Dirk Tourwé, Lauren Jeannin, Koen Iterbeke and P. August Schubiger
      Journal of Nuclear Medicine November 1, 1999, 40 (11) 1913-1917;

  2. Acton, Paul D.

    1. Effects of Age on Dopamine Transporters in Healthy Humans
      P. David Mozley, Paul D. Acton, Eleathea D. Barraclough, Karl Plössl, Ruben C. Gur, Abass Alavi, Ajit Mathur, Janet Saffer and Hank F. Kung
      Journal of Nuclear Medicine November 1, 1999, 40 (11) 1812-1817;

  3. Alavi, Abass

    1. Effects of Age on Dopamine Transporters in Healthy Humans
      P. David Mozley, Paul D. Acton, Eleathea D. Barraclough, Karl Plössl, Ruben C. Gur, Abass Alavi, Ajit Mathur, Janet Saffer and Hank F. Kung
      Journal of Nuclear Medicine November 1, 1999, 40 (11) 1812-1817;

  4. Alberto, Roger

    1. Organometallic 99mTc-Aquaion Labels Peptide to an Unprecedented High Specific Activity
      André Egli, Roger Alberto, Lesley Tannahill, Roger Schibli, Ulrich Abram, Andreas Schaffland, Robert Waibel, Dirk Tourwé, Lauren Jeannin, Koen Iterbeke and P. August Schubiger
      Journal of Nuclear Medicine November 1, 1999, 40 (11) 1913-1917;

  5. Bailey, Katherine M.

    1. Nuclear Medicine Pioneer: John G. McAfee, MD
      Katherine M. Bailey
      Journal of Nuclear Medicine November 1, 1999, 40 (11) 15N-16N;

  6. Baldwin, Ronald M.

    1. Graphical Analysis and Simplified Quantification of Striatal and Extrastriatal Dopamine D2 Receptor Binding with [123I] Epidepride SPECT
      Masanori Ichise, Masahiro Fujita, John P. Seibyl, N. Paul L.G. Verhoeff, Ronald M. Baldwin, Sami S. Zoghbi, Nallakkandi Rajeevan, Dennis S. Charney and Robert B. Innis
      Journal of Nuclear Medicine November 1, 1999, 40 (11) 1902-1912;

  7. Ballangrud, Åse M.

    1. Pharmacokinetics and Dosimetry of an α-Particle Emitter Labeled Antibody: 213Bi-HuM195 (Anti-CD33) in Patients with Leukemia
      George Sgouros, Åse M. Ballangrud, Joseph G. Jurcic, Michael R. McDevitt, John L. Humm, Yusuf E. Erdi, Bipin M. Mehta, Ronald D. Finn, Steven M. Larson and David A. Scheinberg
      Journal of Nuclear Medicine November 1, 1999, 40 (11) 1935-1946;

  8. Barraclough, Eleathea D.

    1. Effects of Age on Dopamine Transporters in Healthy Humans
      P. David Mozley, Paul D. Acton, Eleathea D. Barraclough, Karl Plössl, Ruben C. Gur, Abass Alavi, Ajit Mathur, Janet Saffer and Hank F. Kung
      Journal of Nuclear Medicine November 1, 1999, 40 (11) 1812-1817;

  9. Bax, Jeroen J.

    1. Prediction of Improvement of Regional Left Ventricular Function After Revascularization Using Different Perfusion—Metabolism Criteria
      Jeroen J. Bax, Frans C. Visser, Abdou Elhendy, Don Poldermans, Jan H. Cornel, Arthur van Lingen, Eric Boersma, Gerrit W. Sloof, Paolo M. Fioretti and Cees A. Visser
      Journal of Nuclear Medicine November 1, 1999, 40 (11) 1866-1873;
    2. Fluorodeoxyglucose Imaging to Assess Myocardial Viability: PET, SPECT or Gamma Camera Coincidence Imaging?
      Jeroen J. Bax and William Wijns
      Journal of Nuclear Medicine November 1, 1999, 40 (11) 1893-1895;

  10. Beauchamp, R. Daniel

    1. Optimal Interpretation of FDG PET in the Diagnosis, Staging and Management of Pancreatic Carcinoma
      Dominique Delbeke, D. Michael Rose, William C. Chapman, C. Wright Pinson, J. Kelly Wright, R. Daniel Beauchamp, Yu Shyr and Steven D. Leach
      Journal of Nuclear Medicine November 1, 1999, 40 (11) 1784-1791;
« Previous (Pages : 1 2 3 4 5 6 ... 19) Next »
Back to top

In this issue